Literature DB >> 17057137

Rapid onset of haemodynamic effects after angiotensin converting enzyme-inhibitor overdose: implications for initial patient triage.

C Lucas1, G A Christie, W S Waring.   

Abstract

BACKGROUND: Angiotensin converting enzyme (ACE)-inhibitor overdose may result in severe hypotension. Existing data do not adequately deal with the likely onset of haemodynamic effects, which has implications for the appropriate duration of monitoring in the acute-care setting. Therefore, the relationship between the interval after an ACE-inhibitor overdose and onset of hypotension was examined.
METHODS: A retrospective case review of patients who attended our institution after an ACE-inhibitor overdose between 1 January 2000 and 31 December 2005 was carried out. Data collected were heart rate, blood pressure, electrolytes, electrocardiogram variables, and interval between ingestion and lowest recorded blood pressure.
RESULTS: 33 patients (24 men) who presented after an ACE-inhibitor overdose were identified. Median (interquartile range (IQR)) age was 49 (42-56) years, and stated quantity ingested was 20 (7-42) times the defined daily dose. The median (IQR) interval between ACE-inhibitor ingestion and lowest recorded systolic blood pressure was 4.5 (3.8-5.5) h, diastolic blood pressure was 3.8 (3.3-6.5) h and mean blood pressure was 4.2 (3.5-5.5) h. Heart rate did not increase substantially in response.
CONCLUSION: The lowest blood pressure was recorded within a short interval after an ACE-inhibitor overdose, irrespective of therapeutic intervention. Patients in whom hypotension has not occurred within 6 h of ingestion can be considered for discharge.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057137      PMCID: PMC2464381          DOI: 10.1136/emj.2006.038836

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  23 in total

Review 1.  Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.

Authors:  José López-Sendón; Karl Swedberg; John McMurray; Juan Tamargo; Aldo P Maggioni; Henry Dargie; Michal Tendera; Finn Waagstein; Jan Kjekshus; Philippe Lechat; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

Review 2.  Management of overdose due to antihypertensive agents.

Authors:  G D Johnston; A M Smith
Journal:  Adverse Drug React Acute Poisoning Rev       Date:  1990

3.  Lisinopril overdose.

Authors:  A H Dawson; D Harvey; A J Smith; M Taylor; I M Whyte; C I Johnson; R B Cubela; M J Roberts
Journal:  Lancet       Date:  1990-02-24       Impact factor: 79.321

4.  Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002.

Authors:  K Bennett; H Johnson; P Dack; E Shelley; J Feely
Journal:  Ir J Med Sci       Date:  2005 Jul-Sep       Impact factor: 1.568

5.  Aminophylline reversal of antihypertensive agent toxicity.

Authors:  R J Roberge; M L Rossetti; J M Rosetti
Journal:  Vet Hum Toxicol       Date:  2001-10

6.  Consequences of angiotensin-converting enzyme inhibitor overdose.

Authors:  A Varughese; A A Taylor; E B Nelson
Journal:  Am J Hypertens       Date:  1989-05       Impact factor: 2.689

7.  Captopril overdose resulting in hypotension.

Authors:  W L Augenstein; K W Kulig; B H Rumack
Journal:  JAMA       Date:  1988-06-10       Impact factor: 56.272

8.  Investigation of reflexes from volume and baroreceptors during converting-enzyme inhibition in humans.

Authors:  C Giannattasio; G Grassi; G Seravalle; A Morganti; A Zanchetti; G Mancia
Journal:  Am Heart J       Date:  1989-03       Impact factor: 4.749

9.  Managing heart failure in primary care: first steps in implementing the National Service Framework.

Authors:  Shamini Gnani; Jeremy Gray; Kamlesh Khunti; Azeem Majeed
Journal:  J Public Health (Oxf)       Date:  2004-03       Impact factor: 2.341

Review 10.  Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.

Authors:  Jessica C Song; C Michael White
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 5.577

View more
  3 in total

1.  Indicators for serious kidney complications associated with toxic exposures: an analysis of the National Poison Data System.

Authors:  A M Vilay; C S Wong; R M Schrader; R C Mercier; S A Seifert
Journal:  Clin Toxicol (Phila)       Date:  2013-01-19       Impact factor: 4.467

2.  Variability in the quality of overdose advice in Summary of Product Characteristics (SPC) documents: gut decontamination recommendations for CNS drugs.

Authors:  Andrew J B Wall; D N Bateman; W S Waring
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

3.  Naloxone as an antidote for angiotensin converting enzyme inhibitor poisoning: a case report.

Authors:  Vatsal Trivedi; Bryan A Glezerson; Dipayan Chaudhuri; Morgan Davidson; Ghislaine Douflé
Journal:  Can J Anaesth       Date:  2020-04-27       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.